Proof the Pill can make you fat? Major study finds women on the contraception are more likely to need weight loss jabs

Taking the pill makes women more likely to need the help of weight-loss injections to melt away stubborn fat, a new study suggests.

Danish researchers found that women who used hormonal birth control were up to 63 percent more likely to be prescribed weight-loss injections such as Wegovy and Ozempic later in life.

Those who have tried more than one birth control method in their lifetime face a double risk of using weight loss therapy.

Women have long reported weight changes after starting birth control, but scientific studies have yet to prove the link.

But the authors of the study, led by Copenhagen University Hospital, say their findings match the experiences of many women around the world.

The findings echo those of a study published last year in the National Library of Medicine, which found that 73 per cent of British women reported weight gain associated with taking the pill.

Some experts have suggested that the disruption of natural estrogen and progesterone levels caused by birth control may trigger water retention and increased appetite.

According to data, around a quarter of UK women aged 16-49 use hormonal contraception; The combined pill is most commonly used.

For research, scientistsHealth records of nearly 250,000 women aged 12 to 49 in Denmark were analyzed.

This includes 22,694 women who used semaglutide, also known as Ozempic and Wegovy, at some point and 226,940 women who did not.

The researchers did not have access to each person’s BMI information, but noted that 75 percent of weight-loss vaccine users were overweight or obese.

By comparison, only 11.5 percent of women who did not start semaglutide were obese and about 20 percent were overweight.

Their study examined the use of the combined pill, which contains the hormones estrogen and progestogen (the synthetic version of the hormone progesterone), and the mini-pill, which is a tablet containing only progestogen.

It also included implants, vaginal rings and patches, as well as hormonal intrauterine devices known as IUDs, which are used to prevent pregnancy.

The team found that women taking the combination pill were 42 percent more likely to start semaglutide.

While those taking the mini pill had a 55 percent higher risk, this rate was 63 percent higher in women using the hormonal coil.

Meanwhile, this rate was 64 percent higher in women who switched from the combined pill to the mini pill; This rate increased to 70 percent in those who changed tablets in the opposite direction.

Those who switched from combination pills to hormonal coils were also 80 percent more likely to start weight-loss injections.

But the biggest link appeared to come from women who had used more than one different birth control method and were 111 percent more likely to use semaglutide.

The authors of the study, published in the journal Jama Network Open, suggested that their findings could be explained by the fact that women who use birth control pills spend more face-to-face time with healthcare professionals and thus have increased opportunities to access weight-loss treatment.